Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Ovagen

Glu-Asp-Leu, Liver Bioregulator Peptide

Quick Stats
Studies 34
Trials 30
Score 2
1998 pubmed

The effect of gonadotrophin releasing hormone and follicle stimulating hormone in conjunction with pregnant mare serum gonadotrophin on the superovulatory response in crossbred sheep in India.

Naqvi. S M SM; Gulyani. R R

Key Findings

  • GnRH (4 µg Buserelin) combined with PMSG (800 IU) raised ovulation from ~3 to ~9 corpora lutea per ewe.
  • Adding FSH (0.5 U ovagen) to PMSG lowered ovulation rates compared to PMSG alone.
  • GnRH sped up the onset of estrus regardless of other hormone combinations.

Practical Outcomes

  • For people experimenting with fertility‑related hormone protocols, the data suggest that a GnRH boost can enhance ovarian response when using gonadotropins like PMSG (or its human equivalents). However, adding FSH at the tested low dose may not improve, and could even diminish, egg yield. The findings are specific to sheep and may not translate directly to humans, but they reinforce the known benefit of GnRH in synchronizing and amplifying ovulatory responses.

Summary

In a study on Indian crossbred sheep, adding a small dose of GnRH (Buserelin) to the standard hormone PMSG boosted the number of eggs released, while adding FSH (ovagen) actually reduced egg numbers. GnRH also made the sheep come into heat earlier.

Abstract

Thirty-two mature crossbred (Fine Wool Synthetic, FWS) sheep developed for fine wool production in India were treated for superovulation and oestrus synchronization in spring season. The ewes were randomly allocated to four treatment groups in a factorially designed experiment. For induction of superovulation, pregnant mare serum gonadotrophin (PMSG) was administered alone (group 1), in combination with gonadotrophin releasing hormone (GnRH) (group 2) or with follicle stimulating hormone (FSH) (group 3) and with both (group 4). Oestrus was synchronized in all the ewes by two injections of prostaglandin F2 alpha (PGF, 10 mg each) administered at an interval of 10 days. Superovulation treatment started 48 h prior to the second PGF injection. The proportion of ewes in oestrus did not differ significantly (p > 0.05) in the four groups. The use of GnRH set the ewes into oestrus earlier than the ewes in the other groups. Treatment with PMSG (800 IU) in conjunction with 4 micrograms of Buserilin (GnRH) increased the ovulation rate (9.1 +/- 2.6 corpora lutea (CL)) above that observed when PMSG was used alone (3.0 +/- 0.7 CL). The use of FSH (0.5 U ovagen) in conjunction with PMSG was characterized by a decrease in the proportion of ewes with < or = 2 CL (4/8 vs 7/8; p < 0.05) and in the number of ovulations, i.e. CL observed (2.4 +/- 0.6 vs 9.1 +/- 2.6), and a nonsignificant increase in the incidence of large follicles (LF) (4.6 +/- 1.28 vs 3.25 +/- 0.6; p > 0.05). The interaction between treatments of FSH and GnRH was not significant (p > 0.05). It is concluded that use of GnRH, in conjunction with either PMSG alone or PMSG plus FSH treatment, advanced the onset of oestrus and increased the ovulation rate in FWS sheep.

Study Information

Provider

pubmed

Year

1998

DOI

10.1023/a:1005196705369